Disseminated Coccidioidomycosis Refractory to Multi-Drug Therapies in an Immunocompetent Patient

Razi Syed Haq, Farbod Farmand, Anthony Rajasingham, Sharon Wang, Lloyd Muzangwa and Samuel Beaujean
Additional contact information
Anthony Rajasingham: Department of Internal Medicine, Arrowhead Regional Medical Center, USA
Sharon Wang: Department of Infectious Disease, Arrowhead Regional Medical Center, USA
Samuel Beaujean: St George’s University School of Medicine, West Indies

Open Access Journal of Neurology & Neurosurgery, 2019, vol. 11, issue 2, 40-43

Abstract: Coccidioidomycosis is a fungal infection caused by Coccidioides immitis which thrives in dry desert climates such as the southwestern United States. Disseminated coccidioidomycosis is often seen in patients with an underlying immunodeficiency. Historically there have been few reported cases of opportunistic infections in the setting of low CD4+ count and no evidence of HIV infection. Coccidioidomycosis typically presents asymptomatically or as a minor respiratory illness in immunocompetent individuals. We report a case of disseminated coccidioidomycosis in a patient who is otherwise immunocompetent. Patient is a 24-year-old Hispanic male who presented with severe headache, fever, body pain, vomiting, and diarrhea for approximately 14 days. On admission, patient’s CD4+ count was 91 and CSF culture grew Coccidioides immitis, for which patient was started on fluconazole. Patient’s hospital stay was complicated by multiple bouts of altered mental status, fevers, hyponatremia, hydrocephalus, neurogenic bladder, new-onset Mobitz II heart arrhythmia, urinary tract infection, and sepsis. MRI studies revealed abnormal enhancement of leptomeninges, bilateral basal ganglia, thecal sac and cauda equina fibers, signifying disseminated disease. Patient’s serum Coccidioides complement fixation (IgG) titers remained elevated despite aggressive therapy with IV amphotericin B. After a total of six months of hospitalization, including treatment with intrathecal amphotericin B, patient’s last CD4+ count was 549, CSF IgG titers achieved

Keywords: Open Access Journal of Neurology; Journal of Neurology & Neurosurgery; Open Access Journal; juniper publishers; neurology open access journals; journal of neurology; neurology indexed journals; neurology scholarly journals; journal of neurology; neurology journals impact factor; juniper publishers reivew (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/oajnn/pdf/OAJNN.MS.ID.555809.pdf (application/pdf)
https://juniperpublishers.com/oajnn/OAJNN.MS.ID.555809.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:joajnn:v:11:y:2019:i:2:p:40-43

DOI: 10.19080/OAJNN.2019.11.555809

Access Statistics for this article

Open Access Journal of Neurology & Neurosurgery is currently edited by Sophia Mathis

More articles in Open Access Journal of Neurology & Neurosurgery from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().